Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells

Experimental Cell Research

Volumn 314, Issue 16, 2008, Pages 3017-3026

  Ikeda, Ryuji ^a   Iwashita, Ken ichi ^a   Sumizawa, Tomoyuki ^a   Beppu, Shun ichi ^a   Tabata, Sho ^a   Tajitsu, Yusuke ^a   Shimamoto, Yuichi ^a   Yoshida, Kenichi ^b   Furukawa, Tatsuhiko ^a   Che, Xiao Fang ^a   Yamaguchi, Tatsuya ^a   Ushiyama, Mina ^a   Miyawaki, Akihiko ^a   Takeda, Yasuo ^a   Yamamoto, Masatatsu ^a   Zhao, Hong Ye ^a   Shibayama, Yoshihiko ^a   Yamada, Katsushi ^a   Akiyama, Shin ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b MEIJI UNIVERSITY   (Japan)

Author keywords

Akt; Colon cancer; Hyperosmotic stress; Lung resistance related protein; Major vault protein; p38 MAPK; RNAi; Sodium chloride; Sucrose; SW620

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; LUNG RESISTANCE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SODIUM CHLORIDE; SUCROSE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPEROSMOTIC STRESS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RNA INTERFERENCE; UPREGULATION;

EID: 51849157703     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.001     Document Type: Article

References (35)

1. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J., Clevers H.C., and Scheper R.J. The drug resistance-related protein LRP is the human major vault protein. Nat. Med. 1 (1995) 578-582
2. Scheper R.J., Broxterman H.J., Scheffer G.L., Kaaijk P., Dalton W.S., van Heijningen T.H., van Kalken C.K., Slovak M.L., de Vries E.G., van der Valk P., Meijer C.J., and Pinedo H.M. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer. Res. 53 (1993) 1475-1479
3. Scheffer G.L., Schroeijers A.B., Izquierdo M.A., Wiemer E.A., and Scheper R.J. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr. Opin. Oncol. 12 (2000) 550-556
4. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., and Akiyama S. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J. Natl. Cancer. Inst. 91 (1999) 1647-1653
5. Pohl G., Suchomel R.W., Stranzl T., Depisch D., Stiglbauer W., Filipits M., and Pirker R. Expression of the lung resistance protein in primary colorectal carcinomas. Anticancer. Res. 21 (2001) 201-204
6. Meijer G.A., Schroeijers A.B., Flens M.J., Meuwissen S.G., van der Valk P., Baak J.P., and Scheper R.J. Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. J. Clin. Pathol. 52 (1999) 450-454
7. Hu Y., Stephen A.G., Cao J., Tanzer L.R., Slapak C.A., Harrison S.D., Devanarayan V., Dantzig A.H., Starling J.J., Rome L.H., and Moore R.E. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Int. J. Cancer. 97 (2002) 149-156
8. Mossink M.H., van Zon A., Scheper R.J., Sonneveld P., and Wiemer E.A. Vaults: a ribonucleoprotein particle involved in drug resistance?. Oncogene 22 (2003) 7458-7467
9. van Zon A., Mossink M.H., Schoester M., Scheper R.J., Sonneveld P., and Wiemer E.A. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer. Res. 64 (2004) 4887-4892
10. Huffman K.E., and Corey D.R. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 44 (2005) 2253-2261
11. Stein U., Jurchott K., Schlafke M., and Hohenberger P. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients. J. Clin. Oncol. 20 (2002) 3282-3292
12. Stein U., Walther W., Laurencot C.M., Scheffer G.L., Scheper R.J., and Shoemaker R.H. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. J. Natl. Cancer. Inst. 89 (1997) 807-813
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227 (1970) 680-685
14. Andersen J.K. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10 (1984) 203-209
15. Shimamoto Y., Sumizawa T., Haraguchi M., Gotanda T., Jueng H.C., Furukawa T., Sakata R., and Akiyama S. Direct activation of the human major vault protein (MVP) gene by DNA-damaging agents. Oncol. Rep. 15 (2005) 645-652
16. Zheng C.L., Sumizawa T., Che X.F., Tsuyama S., Furukawa T., Haraguchi M., Gao H., Gotanda T., Jueng H.C., Murata F., and Akiyama S. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochem. Biophys. Res. Commun. 326 (2005) 100-107
17. Miyazawa T., Kubo E., Takamura Y., and Akagi Y. Up-regulation of P-glycoprotein expression by osmotic stress in rat sugar cataract. Exp. Eye. Res. 84 (2007) 246-253
18. Lange C., Walther W., Schwabe H., and Stein U. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem. Biophys. Res. Commun. 278 (2000) 125-133
19. Cowan K.J., and Storey K.B. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206 (2003) 1107-1115
20. Kowalski M.P., Dubouix-Bourandy A., Bajmoczi M., Golan D.E., Zaidi T., Coutinho-Sledge Y.S., Gygi M.P., Gygi S.P., Wiemer E.A., and Pier G.B. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 317 (2007) 130-132
21. Sugawara I., Akiyama S., Scheper R.J., and Itoyama S. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer. Lett. 112 (1997) 23-31
22. Unwin R.D., Harnden P., Pappin D., Rahman D., Whelan P., Craven R.A., Selby P.J., and Banks R.E. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 3 (2003) 45-55
23. Dmitrieva N.I., and Burg M.B. Hypertonic stress response. Mutat. Res. 569 (2005) 65-74
24. Izquierdo M.A., Shoemaker R.H., Flens M.J., Scheffer G.L., Wu L., Prather T.R., and Scheper R.J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer. 65 (1996) 230-237
25. Laurencot C.M., Scheffer G.L., Scheffer R.J., and Shoemaker R.H. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int. J. Cancer 72 (1997) 1021-1026
26. Kickhoefer V.A., Rajavel K.S., Scheffer G.L., Dalton W.S., Scheper R.J., and Rome L.H. Vaults are up-regulated in multidrug-resistant cancer cell lines. J. Biol. Chem. 273 (1998) 8971-8974
27. Komarov P.G., Shtil A.A., Holian O., Tee L., Buckingham L., Mechetner E.B., Roninson I.B., and Coon J.S. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol. Res. 10 (1998) 185-192
28. Berger W., Elbling L., and Micksche M. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int. J. Cancer. 88 (2000) 293-300
29. Meschini S., Marra M., Calcabrini A., Monti E., Gariboldi M., Dolfini E., and Arancia G. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol. In Vitro 16 (2002) 389-398
30. Asakuno K., Kohno K., Uchiumi T., Kubo T., Sato S., Isono M., and Kuwano M. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem. Biophys. Res. Commun. 199 (1994) 1428-1435
31. Ohga T., Uchiumi T., Makino Y., Koike K., Wada M., Kuwano M., and Kohno K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273 (1998) 5997-6000
32. Stein U., Jürchott K., Walther W., Bergmann S., Schla P.M., and Royer H.D. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J. Biol. Chem. 276 (2001) 28562-28569
33. Yi C., Li S., Chen X., Wiemer E.A.C., Wang J., Wei N., and Deng X.W. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res. 65 (2005) 5835-5840
34. Kolli S., Zito C.I., Mossink M.H., Wiemer E.A., and Bennett A.M. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279 (2004) 29374-29385
35. Schwartz L.M., and Osborne B.A. Programmed cell death, apoptosis and killer genes. Immunol. Today 14 (1993) 582-590